Morgan Stanley’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $115K | Buy |
14,926
+3,098
| +26% | +$23.9K | ﹤0.01% | 6081 |
|
|
2025
Q1 | $70.3K | Sell |
11,828
-16,523
| -58% | -$98.2K | ﹤0.01% | 6160 |
|
|
2024
Q4 | $377K | Buy |
28,351
+12,162
| +75% | +$162K | ﹤0.01% | 5542 |
|
|
2024
Q3 | $132K | Buy |
16,189
+6,404
| +65% | +$52.1K | ﹤0.01% | 5890 |
|
|
2024
Q2 | $83.2K | Sell |
9,785
-44,060
| -82% | -$375K | ﹤0.01% | 6025 |
|
|
2024
Q1 | $934K | Sell |
53,845
-89,625
| -62% | -$1.55M | ﹤0.01% | 4984 |
|
|
2023
Q4 | $1.84M | Buy |
143,470
+54,883
| +62% | +$704K | ﹤0.01% | 4968 |
|
|
2023
Q3 | $3.28M | Sell |
88,587
-11,524
| -12% | -$426K | ﹤0.01% | 4042 |
|
|
2023
Q2 | $4.03M | Sell |
100,111
-17,778
| -15% | -$716K | ﹤0.01% | 3935 |
|
|
2023
Q1 | $8.55M | Buy |
117,889
+10,299
| +10% | +$747K | ﹤0.01% | 3279 |
|
|
2022
Q4 | $8.82M | Sell |
107,590
-10,367
| -9% | -$850K | ﹤0.01% | 3203 |
|
|
2022
Q3 | $11.1M | Sell |
117,957
-10,998
| -9% | -$1.04M | ﹤0.01% | 2841 |
|
|
2022
Q2 | $25.1M | Buy |
128,955
+7,374
| +6% | +$1.44M | ﹤0.01% | 2034 |
|
|
2022
Q1 | $28.2M | Buy |
121,581
+19,859
| +20% | +$4.61M | ﹤0.01% | 1765 |
|
|
2021
Q4 | $40.1M | Sell |
101,722
-10,668
| -9% | -$4.2M | ﹤0.01% | 1509 |
|
|
2021
Q3 | $50.3M | Sell |
112,390
-9,040
| -7% | -$4.05M | 0.01% | 1287 |
|
|
2021
Q2 | $47.2M | Sell |
121,430
-5,879
| -5% | -$2.29M | 0.01% | 1350 |
|
|
2021
Q1 | $45.7M | Sell |
127,309
-17,689
| -12% | -$6.35M | 0.01% | 1231 |
|
|
2020
Q4 | $71.2M | Buy |
144,998
+92,600
| +177% | +$45.4M | 0.01% | 885 |
|
|
2020
Q3 | $17M | Buy |
52,398
+21,297
| +68% | +$6.9M | ﹤0.01% | 1599 |
|
|
2020
Q2 | $11.3M | Sell |
31,101
-107,392
| -78% | -$39.1M | ﹤0.01% | 1862 |
|
|
2020
Q1 | $29.5M | Buy |
138,493
+21,179
| +18% | +$4.51M | 0.01% | 1027 |
|
|
2019
Q4 | $48.3M | Sell |
117,314
-830
| -0.7% | -$342K | 0.01% | 955 |
|
|
2019
Q3 | $41.7M | Buy |
118,144
+38,242
| +48% | +$13.5M | 0.01% | 964 |
|
|
2019
Q2 | $40.2M | Buy |
79,902
+28,604
| +56% | +$14.4M | 0.01% | 968 |
|
|
2019
Q1 | $51M | Sell |
51,298
-21,928
| -30% | -$21.8M | 0.01% | 822 |
|
|
2018
Q4 | $63.6M | Sell |
73,226
-2,379
| -3% | -$2.07M | 0.02% | 707 |
|
|
2018
Q3 | $78.2M | Sell |
75,605
-6,073
| -7% | -$6.28M | 0.02% | 720 |
|
|
2018
Q2 | $75M | Sell |
81,678
-4,677
| -5% | -$4.3M | 0.02% | 714 |
|
|
2018
Q1 | $84.2M | Buy |
86,355
+16,883
| +24% | +$16.5M | 0.02% | 662 |
|
|
2017
Q4 | $31.4M | Buy |
69,472
+11,966
| +21% | +$5.41M | 0.01% | 1301 |
|
|
2017
Q3 | $23.8M | Buy |
57,506
+18,044
| +46% | +$7.47M | 0.01% | 1437 |
|
|
2017
Q2 | $13.8M | Buy |
39,462
+32,460
| +464% | +$11.4M | ﹤0.01% | 1853 |
|
|
2017
Q1 | $3.6M | Buy |
7,002
+4,174
| +148% | +$2.14M | ﹤0.01% | 3221 |
|
|
2016
Q4 | $1M | Buy |
2,828
+2,521
| +821% | +$895K | ﹤0.01% | 4459 |
|
|
2016
Q3 | $164K | Buy |
307
+156
| +103% | +$83.3K | ﹤0.01% | 5097 |
|
|
2016
Q2 | $85K | Sell |
151
-85
| -36% | -$47.8K | ﹤0.01% | 5310 |
|
|
2016
Q1 | $112K | Sell |
236
-4,802
| -95% | -$2.28M | ﹤0.01% | 5265 |
|
|
2015
Q4 | $3.33M | Buy |
5,038
+4,265
| +552% | +$2.82M | ﹤0.01% | 3051 |
|
|
2015
Q3 | $608K | Buy |
773
+532
| +221% | +$418K | ﹤0.01% | 4485 |
|
|
2015
Q2 | $318K | Buy |
241
+237
| +5,925% | +$313K | ﹤0.01% | 4983 |
|
|
2015
Q1 | $4K | Sell |
4
-27
| -87% | -$27K | ﹤0.01% | 6361 |
|
|
2014
Q4 | $20K | Buy |
+31
| New | +$20K | ﹤0.01% | 6046 |
|